• 1
    Novak ER, Jones GS, Jones HW Jr. Novak's textbook of gynecology, 7th ed. Baltimore: Williams and Wilkins, 1965.
  • 2
    TeLinde RW. Operative gynecology, 1st ed. Philadelphia: JB Lippincott, 1946.
  • 3
    Curtis AH. A textbook of gynecology. Philadelphia: WB Saunders, 1946.
  • 4
    Ranney B, Ahmad MI. Early identification, differentiation and treatment of ovarian neoplasia. Int J Gynecol Obstet. 1979; 17: 209218.
  • 5
    Wikborn C, Pettersson F, Silfverswärd C, Moberg PJ. Symptoms and diagnostic difficulties in ovarian epithelial cancer. Int J Gynecol Obstet. 1993; 42: 261264.
  • 6
    Flam F, Einhorn N, Sjövall K. Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1988; 27: 5357.
  • 7
    Smith EM, Anderson B. The effects of symptoms and delay in seeking diagnosis on stage of disease at diagnosis among women with cancers of the ovary. Cancer. 1985; 56: 27272732.
  • 8
    Goff BA, Mandell L, Mintz HG, Melancon CH. Ovarian carcinoma diagnosis: results of a national survey. Cancer. 2000; 89: 20682075.
  • 9
    Vine MF, Ness RB, Calingaert B, Schildkraut JM, Berchuck A. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol. 2001; 83: 466471.
  • 10
    Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of ovarian cancer. Obstet Gynecol. 2001; 98: 212217.
  • 11
    Webb PM, Purdie DM, Grover S, Jordan S, Dick M-L, Green AC. Symptoms and diagnosis of borderline, early and advance epithelial ovarian cancer. Gynecol Oncol. 2004; 92: 232239.
  • 12
    Koren G, Maltepe C, Navioz Y, Wolpin J. Recall bias of the symptoms of nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2004; 190: 485488.
  • 13
    Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004; 291: 27052712.
  • 14
    Hoskins WJ, McGuire WP, Bardy MF, et al. The effect of diameter of largest residual disease on survival after primary cyto-reactive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994; 170: 974979.
  • 15
    Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002; 40( Suppl IV): 3–18.
  • 16
    Sightler SE, Boike GM, Estape RE, Averette HE. Ovarian cancer in women with prior hysterectomy: a 14 year experience at the University of Miami. Obstet Gynecol. 1991; 78: 681684.
  • 17
    McGowan L. Ovarian cancer after hysterectomy. Obstet Gynecol. 1987; 69: 386389.
  • 18
    Fowles JB, Lawthers AG, Weiner JP, et al. Agreement between physician's office records and Medicare Part B claims data. Health Care Finance Rev. 1995; 16: 189199.
  • 19
    Horiuchi A, Itoh K, Shimizu M, et al. Toward understanding the natural history of ovarian carcinoma development: a clinicopathologic approach. Gynecologic Oncol. 2003; 88: 309317.
  • 20
    Warren J, editor. Use of the SEER-Medicare data for cancer-related health services research. Med Care. 2002; 40( Suppl IV): 1117.
  • 21
    Solz H, Gilbert K. Health Claims Data as a strategy and tool in disease management. J Ambul Care Manage. 2001; 24: 6985.
  • 22
    Quam L, Ellis LBM, Venus P, Clouse J, Taylor CJ, Leatherman S. Using claims data for epidemiologic research. Med Care. 1993; 31: 498507.
  • 23
    DiSaia PJ, Creasman WT. Clinical gynecologic oncology, 5th ed. Mosby, 1997.